Boehringer Ingelheim Canada Ltd.
Registration:
2
of
6
(2022-06-24
to
2023-06-01)
Policies or Program
- Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
- Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).